SCHEMBL6978161

SCHEMBL6978161

O=C(O)C(=O)CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31277089 0.89 KMT2A (0.40)
SCHEMBL8090333 0.89 KMT2A (0.45)
SCHEMBL8968249 0.88 PLG (0.56)
SCHEMBL9438614 0.88 PLG (0.56)
SCHEMBL3871573 0.87 EPHX1 (0.48)
SCHEMBL13621150 0.79 NCF1 (0.45)
SCHEMBL20329462 0.78 TP53 (0.48)
SCHEMBL15069506 0.76 TFPI2 (0.39)
SCHEMBL18950692 0.75 DRD2 (0.41)
SCHEMBL24483431 0.75 ANPEP (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1337508-A1 PREPARATION OF SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS Pfizer Products Inc. (US) 2003-08-27 EP claimed
WO-2002044133-A1 PREPARATION OF SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS PFIZER PRODUCTS INC. (US) 2002-06-06 WO claimed
CN-113164617-A Compounds for modulating and as a functional replacement for alpha-ketoglutarate (2OG) dependent oxygenase 托马斯·梅尔希奥·霍曼 2021-07-23 CN disclosed
CN-103508948-A Method for preparing pitavastatin calcium ASYMCHEM LAB TIANJIN CO LTD 2014-01-15 CN disclosed
EP-0543245-A1 Renin inhibiting amino acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1993-05-26 EP disclosed
CN-1072413-A Amino acid derivative HOFFMANN LA ROCHE (CH) 1993-05-26 CN disclosed